Skip To Main Content
Zheyu Shao on Muck Rack

Zheyu Shao

As seen in: Wiley Online Library, The BMJ
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Zheyu

Contact Zheyu, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

PD‐1 Inhibits CD4+ TRM‐Mediated cDC1 Mobilization via Suppressing JAML in Human NSCLC

|
By Zheyu Shao, Qinyuan Liu, Zhongwei Xin, Zhiyao Zhou
| Wiley Online Library Verified
1 Introduction Non-small cell lung cancer (NSCLC) remains a leading cause of cancer-related death globally, and despite immunotherapeutic advances, durable responses are achieved only in a subset of patients. A deeper understanding of the local immune landscape is therefore critical for improving clinical outcomes.
Open in Who Shared Issue with article?

Epithelium/imcDC2 axis facilitates the resistance of neoadjuvant anti-PD-1 in human NSCLC

|
By Yongyuan Chen, Zhixing Hao, Zhongwei Xin, Zheyu Shao
| The BMJ Verified
Methods 27 patients with histologically proven NSCLC were allowed to participate in the study. The pathological diagnosis was confirmed by the pathology Department of the Second Affiliated Hospital of Zhejiang University. None of the patients had received radiotherapy or chemotherapy before surgery. Neoadjuvant therapy regimens are performed according to the National Comprehensive Cancer Network (NCCN) guidelines on NSCLC.
Open in Who Shared Issue with article?
See all 2 articles